AP
BTX.WS

Arlington Partners’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Arlington Partners’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-400
Closed – – 274
2018
Q3 		$0 Hold
400
– – ﹤0.01% 227
2018
Q2 		$0 Hold
400
– – ﹤0.01% 151
2018
Q1 		$0 Hold
400
– – ﹤0.01% 143
2017
Q4 		$0 Buy
+400
New +$71 ﹤0.01% 91

Arlington Partners's BTX.WS Position: Q4 2018 in Review

Arlington Partners sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q4 2018, closing a stake of 400 shares.

Arlington Partners first reported a position in BTX.WS in Q4 2017 and held it in 4 quarters. The position peaked at $0 in Q3 2018. 0 funds tracked by Wall St. Rank hold BTX.WS as of Q4 2018.

  • Arlington Partners reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q4 2018 after selling out during the quarter.
  • Arlington Partners sold 400 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q4 2018.
  • Arlington Partners first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2017 and held it in 4 quarters.
  • Arlington Partners's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q3 2018.
  • 0 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q4 2018.

Based on Arlington Partners's 13F filing for Q4 2018, filed 10 Jan 2019.